DN
Dianthus Therapeutics, Inc.
DNTH · NASDAQ
$96.81 -4.26% (-$4.31)
1M -7.66%
Market Cap $5.66B
P/E Ratio -
Div. Yield -
ROE 3.51%
Bulios Fair Price
$70.85
26.8% downside
Trenutna cena
$96.81
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DNTH trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
20 /100
Expensive P/S 2,970.63x
P/B 4.83x
P/E N/A
Growth
22 /100
Declining Rev. growth 31.80%
Book val. growth 88.51%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 96.01%
Net margin 1,570.85%
Op. margin 11,441.40%
Quality
0 /100
Poor ROIC 18.47%
ROE 3.51%
ROA 2.47%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 26.10x
Int. coverage N/A
Stability
5 /100
Unstable Beta 0.08x
Rev. volatility 105.40%
EPS volatility 67.73%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DNTH
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marino Garcia
Employees
92
Headquarters
New York
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report